75 related articles for article (PubMed ID: 8603402)
1. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells.
Rea D; Parker MG
Cancer Res; 1996 Apr; 56(7):1556-63. PubMed ID: 8603402
[TBL] [Abstract][Full Text] [Related]
2. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
[TBL] [Abstract][Full Text] [Related]
4. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
7. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
[TBL] [Abstract][Full Text] [Related]
8. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1.
Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649
[TBL] [Abstract][Full Text] [Related]
9. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Zhang QX; Borg A; Fuqua SA
Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells.
Pfeffer U; Fecarotta E; Vidali G
Cancer Res; 1995 May; 55(10):2158-65. PubMed ID: 7743517
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM
Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466
[TBL] [Abstract][Full Text] [Related]
12. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
[TBL] [Abstract][Full Text] [Related]
13. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
16. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
[TBL] [Abstract][Full Text] [Related]
19. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
Chan CM; Dowsett M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
[TBL] [Abstract][Full Text] [Related]
20. Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance.
Han F; Miksicek R; Clarke R; Conrad SE
J Mol Endocrinol; 2004 Jun; 32(3):935-45. PubMed ID: 15171723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]